Anika Therapeutics (ANIK) P/E (2010 - 2026)
Anika Therapeutics (ANIK) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Anika Therapeutics (ANIK) P/E is -18.13. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Anika Therapeutics (ANIK)
| Year | P/E | Change |
|---|---|---|
| 2026 | -18.13 | +42.57% |
| 2025 | -12.72 | +198.43% |
| 2024 | -4.26 | -68.52% |
| 2023 | -13.53 | -50.49% |
| 2022 | -27.34 | -122.01% |
| 2021 | 124.22 | -560.82% |
| 2020 | -26.96 | -200.33% |
| 2019 | 26.87 | -56.72% |
| 2018 | 62.08 | +131.42% |
| 2017 | 26.83 | +31.32% |
| 2016 | 20.43 | +9.65% |
| 2015 | 18.63 | +18.89% |
| 2014 | 15.67 | -40.36% |
| 2013 | 26.27 | +125.10% |
| 2012 | 11.67 | -38.84% |
| 2011 | 19.08 | -43.46% |
| 2010 | 33.76 | N/A |
Comparison Anika Therapeutics (ANIK) P/E with competitors
Anika Therapeutics (ANIK) P/E is -18.13.